• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PHILIPS NORTH AMERICA LLC HEARTSTART MRX MONITOR/DEFIB; DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PHILIPS NORTH AMERICA LLC HEARTSTART MRX MONITOR/DEFIB; DEFIBRILLATOR Back to Search Results
Model Number M3535A
Device Problems Failure to Deliver Energy (1211); No Pacing (3268)
Patient Problems Cardiac Arrest (1762); Heart Block (4444); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 06/23/2021
Event Type  Injury  
Manufacturer Narrative
A follow-up report will be submitted upon completion of the investigation.
 
Event Description
It was reported to philips the device failed to capture during pacing on patient.Additional details have been requested.The device was reported to be in use on a patient, causing a possible delay in life saving therapy and will be considered a serious injury.However, no direct adverse event to the patient or user was reported.
 
Event Description
It was reported to philips the device failed to capture during pacing on patient.The clinician changed out the pads then changed pads and placement again.Ems applied another manufacturer monitor and immediate capture was obtained.The device was reported to be in use on a patient, causing a possible delay in life saving therapy and will be considered a serious injury.However, no direct adverse event to the patient or user was reported.The customer shipped the device to the philips repair bench to evaluate the device.The repair bench provided the customer with an estimate for evaluation/repair.A philips clinician reviewed the patient event file.It was found the device was powered on in monitoring mode with lead ii as the ecg source.No ecg waveform was visible from this source which would indicate that the leads were not connected to the patient.At 4:17 elapsed time, a ¿pads on¿ message was observed and the ecg lead source changed to pads automatically as designed.The ecg showed p waves (clinical asystole) followed by an erratic third degree av heart block with wide qrs complexes.At 6:11 elapsed time, the device was placed into pacer mode in the default setting of ¿demand¿.A ¿leads on¿ message was observed at 6:58 elapsed time and the ecg source switched to lead ii.The ecg was third degree heart block alternating with asystole.Pacing was started at 7:04 elapsed time at a rate of 60 paced pulses per minute (ppm) and an output of 80 ma.No electrical capture of the patient¿s heart rhythm was observed.The following changes to the pacer setting were subsequently ma;de: 00:07:42 , pacer change rate, 70 ppm; 00:07:44 , pacer change rate, 60 ppm; 00:07:47 , pacer change output, 85 ma; 00:07:48 , pacer change output, 90 ma; 00:07:52 , pacer change rate, 70 ppm; 00:09:34 , pacer change output, 95 ma; 00:09:35 , pacer change output, 90 ma; 00:10:03 , pacer change output, 95 ma; 00:10:03 , pacer change output, 100 ma; 00:11:09 , pacer change rate, 80 ppm; 00:15:11 , pacer mode change fixed 00:15:47 , pacer change output, 95 ma; 00:15:47 , pacer change output, 90 ma; 00:16:08 , pacer change output, 95 ma; 00:16:09 , pacer change output, 100 ma; numerous extreme bradycardia and asystole alarms 00:35:36 , pacer change output, 110 ma; 00:36:22 , pacer change output, 115 ma; 00:36:22 , pacer change output, 120 ma; 00:38:11 , pacer change output, 125 ma; 00:38:12 , pacer change output, 130 ma; 00:38:12 , pacer change output, 135 ma; 00:38:12 , pacer change output, 140 ma; 00:38:13 , pacer change output, 145 ma; 00:38:13 , pacer change output, 150 ma; 00:38:15 , pacer change output, 145 ma; 00:38:15 , pacer change output, 140 ma; 00:38:16 , pacer change output, 135 ma; 00:38:16 , pacer change output, 130 ma; 00:40:15 , pacer change output, 135 ma; 00:40:15 , pacer change output, 140 ma; 00:43:16 , pacer change output, 145 ma; 00:43:17 , pacer change output, 150 ma; 00:43:43 , pacer change output, 155 ma; 00:43:43 , pacer change output, 160 ma; 00:49:50 , pacer change output, 165 ma; 00:49:50 , pacer change output, 170 ma; 00:51:26 , pacer change rate, 70 ppm; 00:51:31 , pacer change output, 175 ma; 00:51:32 , pacer change output, 175 ma; (ma;ximum) 00:51:33 , pacer change output, 175 ma; 00:51:34 , pacer change output, 175 ma; 00:52:23 nbp 112/59 (77); 00:52:39 pads off; 00:52:40 , pacer stop; 00:53:06 pads on ; 00:54:06 , pacer start; 00:54:40 , pacer change output, 145 ma; 00:54:40 , pacer change output, 150 ma; 00:56:24 nbp 144/106 (119); multiple asystole and extreme bradycardia alarms.00:59:52 , pacer change output, 155 ma; 00:59:52 , pacer change output, 160 ma; 01:07:43 , pacer change output, 165 ma; 01:07:43 , pacer change output, 170 ma; 01:07:44 , pacer change output, 175 ma; 01:07:44 , pacer change output, 175 ma; 01:09:54 , pacer stop; 01:10:06 , nbp 105/54 (71); 01:10:33 , pacer start, 70 ppm; ¿ 175 ma;.Numerous asystole and extreme bradycardia alarms.01:29:06 , nbp 141/92 (108); 01:34:23 , leads off; 01:40:41 , pacer stop; 01:40:44 , pads off; 01:41:30 , device off.Despite attempts at changing the pacing rate, pacer output, and pacer mode over the course of over one hour of therapy, electrical capture was never observed.Pacer output was increased to the maximum setting available twice during the course of this event.It is not possible from the information observed in the device event file to determine how the patient could have blood pressure readings if they were not somehow being perfused as there was no observed electrical capture of the ecg by transcutaneous pacing.One possible explanation is that a second device was being used to deliver transcutaneous pacing therapy.The customer declined repair from philips.The repair bench shipped the device back to the customer unrepaired.The device remains with the customer.No conclusion can be drawn.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTSTART MRX MONITOR/DEFIB
Type of Device
DEFIBRILLATOR
Manufacturer (Section D)
PHILIPS NORTH AMERICA LLC
22100 bothell everett highway
bothell WA 98021
Manufacturer (Section G)
PHILIPS NORTH AMERICA LLC
22100 bothell everett highway
bothell WA 98021
Manufacturer Contact
bethany glynn
22100 bothell everett highway
bothell, WA 98021
9095703538
MDR Report Key12174971
MDR Text Key261751620
Report Number3030677-2021-12979
Device Sequence Number1
Product Code MKJ
UDI-Device Identifier00884838000018
UDI-Public00884838000018
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K031187
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM3535A
Device Catalogue NumberM3535A
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date06/23/2021
Initial Date Manufacturer Received 06/23/2021
Initial Date FDA Received07/15/2021
Supplement Dates Manufacturer Received08/04/2021
Supplement Dates FDA Received01/11/2022
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age50 YR
Patient SexFemale
Patient Weight95 KG
-
-